Abstract
Our objective was to investigate the effect of alanine administration on Na+,K+-ATPase activity in cerebral cortex of rats subjected to chemically-induced phenylketonuria. Wistar rats were treated from the 6th to the 28th day of life with subcutaneous injections of either 2.6 μmol alanine or 5.2 μmol phenylalanine plus 2.6 μmol α-methylphenylalanine per g body weight or phenylalanine plus α-methylphenylalanine plus alanine in the same doses or equivalent volumes of 0.15 M saline. The animals were killed on the 29th or 60th day of life. Synaptic plasma membrane from cerebral cortex was prepared for Na+,K+-ATPase activity determination. The results showed that alanine injection prevents the decrease of Na+,K+-ATPase activity in animals subjected to experimental phenylketonuria. Therefore, in case the same effects are achieved with ingested alanine, it is possible that alanine supplementation may be an important dietary adjuvant for phenylketonuric patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Azen, C.G., Koch, R., Friedman, E.G., Berlow, S., Caldwell, J., Krause, W., et al.(1991). Intellectual development in 12-year-old children treated for phenylketonuria. Am. J. Dis. Child. 145:35–39.
Bick, U., Fahrendorf, G., Ludolph, A.C., Vassallo, P., Weglage, J., and Ullrich, R. (1991). Disturbed myelination in patients with treated hyperphenylalaninemia: Evaluation with magnetic resonance imaging. Eur. J. Pediatr. 150:185–189.
Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
Chan, K.M., Delfert, D., and Junger, K.D. (1986). A direct colorimetric assay for Ca+2-stimulated ATPase activity. Anal. Biochem. 157:375–380.
Chevillard, C., Cárdenas, M.L. and Cornish-Bowden, A. (1993). The competition plot: a simple test of whether two reactions occur at the same active site. Biochem. J. 289:599–604.
Erecinska, M., and Silver, I.A. (1994). Ions and energy in brain mammalian brain. Prog. Neurobiol. 43:37–71.
Grisar, T. (1984). Glial and neuronal Na, K pump in epilepsy. Ann. Neurol. 16:128–134.
Guttler, F., and Lou, H. Phenylketonuria and hyperphenylalaninemia. In: (J. Fernandes, M.-M. Saudubray, K. Tada, eds.) Inborn Metabolic Diseases: Diagnosis and Treatment. Berlin, Heidelberg: Springer-Verlag, 1990 pp. 161–174
Hommes, F.A. (1991). On the mechanism of permanent brain dysfunction in hyperphenylalaninemia. Biochem. Med. Metab. Biol. 46:277–287.
Jonas, D.H., and Matus, A.I. (1974). Isolation of synaptic plasma membrane from brain by combination flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta, 356:276–287.
Krouse, W., Halminski, M., McDonald, L. Dembure, P., Salvo, R., Freides, D., and Elsas, L. (1985). Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J. Clin. Invest. 75:40–48.
Lees G J. (1991). Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain. Res. Rev., 16:283–300.
Lees, G.J. (1993). Contributory mechanisms in the causation of neurodegenative disorders. Neuroscience 54:287–322.
Lees, G.J., Lehmann, A., Sandberg, M., and Hamberger, A. (1990). The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in the rat hippocampus. Neurosci. Lett. 120:155–158.
Lou, H.C., Lykkelund, C., Gerdes, A.M., Udesen, H., and Bruhn, P. (1987). Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr. Scand. 76:560–565.
Lou, H.C., Toft, P.B., Andresen, J., Mikkelsen, I., Olsen, B., Guttler, F., et al.(1992). An occipitotemporal syndrome in adolescents with optimally controlled hyperphenylalaninemia. J. Inher. Metab. Dis. 15:687–696.
Marsden, D., Barshop, B.A., Capistrano-Estrada, S. Rice, M., Prodanus, C., Sartoris, D., et al.(1994). Anabolic effect of human hormone: Management of inherited disorders of catabolic pathways. Biochem. Med. Metab. Biol. 52:145–154.
Scriver, C.R., Kaufman, S., Eisensmith, R.C., and Woo, S.L.C. The hyperphenylalaninemias. In: (C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds.) The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, Inc., New York, 7th Ed., 1995: 1015–1075.
Smith, I., Beasley, M.G. and Ades, A.E. (1990). Intelligence and quality of dietary treatment in phenylketonuria. Arch. Dis. Child. 65:472–478.
Thompson, A.J., Smith, I., Brenton, D., Yaul, B.D., Rylance, G., Davidson, D.C., et al.(1990). Neurological deterioration in young adults with phenylketonria. Lancet 336:602–605.
Tsakiris, S., and Deliconstantinos, G. (1983). Influence of phosphatidylserine on (Na++K+)-stimulated ATPase and acethylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem. J. 220:307–310.
Wyse, A.T.S., Bolognesi, G., Brusque, A.M., Wajner, M., and Wannmacher, C.M.D. (1995a). Na+,K+-ATPase activity in the synaptic plasma membrane from the cerebral cortex of rats subjected to chemically induced phenylketonuria. Med. Sci. Res. 23:261–262.
Wyse, A.T.S., Sarkis, J.J.F., Cunha-Filho, J.S., Teixeira, M.V., Schetinger, M.R., Wajner, M., and Wannmacher, C.M.D. (1994). Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem. Res. 19:1175–1180.
Wyse, A.TS., Wajner, M., Brusque, A.M., and Wannmacher, C.M.D. (1995b). Alanine reverses the inhibitory effect of phenylalanine and its metabolites on Na+,K+-ATPase in synaptic plasma membranes from cerebral cortex of rats. Biochem. Soc. Trans. 23:227S.
Wyse, A.T.S., Wajner, M., and Wannmacher, C.M.D. (1998). Kinetics of alanine reversal on the inhibition of Na+,K+-ATPase activity by phenylalanine and phenyllactate in the synaptic plasma membrane from the cerebral cortex of rats. Med. Sci. Res. 26:141–143.
Zeman, G., Pijackova, A., Behulova, J., Urge, O., Saligova, D., and Hyanek, J. (1996). Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. Eur. J. Pediatr. 155[Suppl 1]:S56-S58.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wyse, A.T., Noriler, M.E., Borges, L.F. et al. Alanine Prevents the Decrease of Na+,K+-ATPase Activity in Experimental Phenylketonuria. Metab Brain Dis 14, 95–101 (1999). https://doi.org/10.1023/A:1020705713548
Issue Date:
DOI: https://doi.org/10.1023/A:1020705713548